Found 12 resultsAuthor [ Title] Year
Filters: First Letter Of Title is A [Clear All Filters]
Availability of COLLECT, a database for pregnancy and placental research studies worldwide. Placenta. 2017;57:223-224..
Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India. Reproductive Health [Internet]. 2018;15(S1). https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-018-0531-6http://link.springer.com/content/pdf/10.1186/s12978-018-0531-6.pdf.
Assessment, surveillance and prognosis in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):449-62..
Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659-665..
An assessment of predictive value of the biophysical profile in women with preeclampsia using data from the fullPIERS database. Pregnancy Hypertens. 2013;3(3):166-71..
Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model. J Obstet Gynaecol Can. 2015;37(1):16-24..
Are women with history of pre-eclampsia starting a new pregnancy in good nutritional status in South Africa and Zimbabwe?. BMC Pregnancy Childbirth. 2018;18(1):236..
Are long-term health risks of pre-eclampsia and intrauterine growth restriction really the same?. BJOG. 2015;122(13):1824..
Advocacy organisations as partners in pre-eclampsia progress: patient involvement improves outcomes. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):523-36..
Advocacy is essential to supporting women with pre-eclampsia. Obstet Med. 2017;10(1):33-35..
An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2. Blood Press Monit. 2015;20(1):52-5..
Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33(10):995-1004..